Table 1.
Characteristics of sarcoidosis patients.
Variable | N |
---|---|
Total sarcoidosis patients | 121 |
Sex | |
Male | 53 (44%) |
Female | 68 (56%) |
Age of diagnosisa | |
20–39 | 33 (27%) |
40–59 | 63 (52%) |
≥60 | 24 (20%) |
Radiological stage during diagnosis | |
0-I | 75 (62%) |
II | 23 (19%) |
III | 3 (3%) |
IV | 2 (2%) |
No record | 18 (15%) |
Smoking history | |
Current smoker | 20 (16.5%) |
Ex-smoker | 28 (23%) |
Never smoker | 47 (38.8) |
No record | 26(21.5%) |
Treatment | |
Steroid (systemic & topical) | 52 (43%) |
Methotrexate | 6 (5%) |
Azathioprine | 6 (5%) |
Mycophenolate | 3 (2.5%) |
Hydroxychloroquine | 4 (3%) |
Infliximab | 1 (0.8%) |
Vital status at the end of follow up | |
Dead | 8 (6.6%) |
Transfer to different hospital | 1 (0.8%) |
Alive | 112 (92.5%) |
1 patient-no information about the year of diagnosis.